How Biology Benefits from Technological Discoveries
summary
Claims rapid acceleration: biology outpaces Moore's Law as sequencing and synthesis costs drop, enabling reprogramming of life to address projected 12 billion people by 2100. Accelerator IndyBio backs 68 companies across ag, cellular therapies and diagnostics with ~$500M cumulative market cap, $100M+ raised, 400+ biotech jobs and 70% funding rate. Concrete outcomes: an implantable artificial kidney in large-animal tests, a stem-cell maker pivoted to increase donor count, a pathogen-test prototype fixed by redesigning the swab, and an AI trial-matching product monetized by selling stratified data to pharma.
AI-written summary · about
chapters (6)
- 0:00Introduction and background
- 3:57Humanity's looming crisis
- 6:26Design meets science
- 7:28Four key lessons
- 12:33Future life science opportunities
- 15:07Conclusion and call to action
related talks
25mBiology's ChatGPT Moment
34mThe True Revolution Lies Ahead of Us
14mBig data, AI, the genome, and everything
17mInnovation, Entrepreneurship & Networks
39mThe Translation Gap
25mHealth Without Borders: Innovation and Capital at the Frontier
21mShaping the future of health: Boehringer Ingelheim's Data & AI Journey
55mImagination and Vision: where small dreams have no place
